Trials / Completed
CompletedNCT00654550
A Study to Assess the Safety, Tolerability and Effect of Nexagon™ Applied to the Eye After PRK Laser Eye Surgery for Nearsightedness
A Phase 1 Randomized, Prospective, Double-Masked, Vehicle-Controlled, Dose-Escalation Study to Evaluate the Safety, Tolerability and Clinical Effect of Nexagon™ in Subjects Following Bilateral Photorefractive Keratectomy (PRK) for the Correction of Mild to Moderate Myopia.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- OcuNexus Therapeutics, Inc. · Industry
- Sex
- All
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
Phase 1 randomized, prospective, double-masked, vehicle-controlled, dose-escalation study to evaluate the safety, tolerability and clinical effect of Nexagon™ in subjects following bilateral PRK for the correction of mild to moderate myopia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nexagon™ or Nexagon™ vehicle | Dose-escalation design in which cohorts of 6 subjects will be studied sequentially. |
Timeline
- Start date
- 2008-04-01
- Primary completion
- 2008-09-01
- Completion
- 2008-12-01
- First posted
- 2008-04-08
- Last updated
- 2009-01-08
Locations
1 site across 1 country: New Zealand
Source: ClinicalTrials.gov record NCT00654550. Inclusion in this directory is not an endorsement.